Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.16−0.04 (-1.82%)
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Minerva Neurosciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Minerva Neurosciences's pe ratio was 2.9× on Oct 31, 2025, against 47.6× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 2.9× | −8.9 |
| 2021 | Jul 30, 2021 | 11.8× | – |
See a number that looks wrong?